GO TO: Recent Comment Letters
ALL |
All 10-K/Qs
Large
Mid
Small
Micro
|
Earnings Release
Proxy
|
SORT BY :
Most Recent
Company Name
| Company | Time | Size | View | Financials | Document | SEC | Period | Revenue MRQ | Assets | EPS Diluted | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10x Genomics, Inc. (TXG) | 8/7/2026 6:12:49 AM | Mid | View | Financials | 10-Q | SEC | 2Q 2026 ending: 6/30/2026 | Rev: $151,036,000 -12.6% | Assets $1,030,066,000 | EPS -$0.14 | |
| 10x Genomics, Inc. (TXG) | 8/6/2026 4:05:16 PM | View | Financials | Earnings | SEC | 2Q 2026 | Rev $151,036,000 -12.6% | Assets $1,030,066,000 | EPS -$0.14 | Export Earnings Model | |
| 10x Genomics, Inc. (TXG) | 5/8/2026 6:13:19 AM | Mid | View | Financials | 10-Q | SEC | 1Q 2026 ending: 3/31/2026 | Rev: $150,843,000 -2.6% | Assets $1,015,759,000 | EPS -$0.10 | |
| 10x Genomics, Inc. (TXG) | 5/7/2026 4:05:39 PM | View | Financials | Earnings | SEC | 1Q 2026 | Rev $150,843,000 -2.6% | Assets $1,015,759,000 | EPS -$0.10 | Export Earnings Model | |
| 10x Genomics, Inc. (TXG) | 4/24/2026 4:15:10 PM | View | Proxy | SEC | Y 2025 | ||||||
| 10x Genomics, Inc. (TXG) | 2/13/2026 6:13:09 AM | Mid | View | Financials | 10-K | SEC | Y 2025 ending: 12/31/2025 | Rev: $642,823,000 +5.2% | Assets $1,041,365,000 | EPS -$0.35 | |
| 10x Genomics, Inc. (TXG) | 2/12/2026 4:10:22 PM | View | Financials | Earnings | SEC | Y 2025 | Rev $166,030,000 +0.6% | Assets $1,041,365,000 | EPS -$0.13 | Export Earnings Model | |
| 10x Genomics, Inc. (TXG) | 1/12/2026 3:53:34 PM | View | Financials | Earnings (Prelim) | SEC | Y 2025 | Export Earnings Model | ||||
| 10x Genomics, Inc. (TXG) | 11/7/2025 6:12:28 AM | Mid | View | Financials | 10-Q | SEC | 3Q 2025 ending: 9/30/2025 | Rev: $149,002,000 -1.7% | Assets $1,027,361,000 | EPS -$0.22 | |
| 10x Genomics, Inc. (TXG) | 11/6/2025 4:12:01 PM | View | Financials | Earnings | SEC | 3Q 2025 | Rev $149,002,000 -1.7% | Assets $1,027,361,000 | EPS -$0.22 | Export Earnings Model | |
| 10x Genomics, Inc. (TXG) | 8/8/2025 6:13:38 AM | Mid | View | Financials | 10-Q | SEC | 2Q 2025 ending: 6/30/2025 | Rev: $172,908,000 +12.9% | Assets $979,970,000 | EPS $0.28 | |
| 10x Genomics, Inc. (TXG) | 8/7/2025 4:19:36 PM | View | Financials | Earnings | SEC | 2Q 2025 | Rev $172,908,000 +12.9% | Assets $979,970,000 | EPS $0.28 | Export Earnings Model | |
| 10x Genomics, Inc. (TXG) | 5/9/2025 6:12:14 AM | Mid | View | Financials | 10-Q | SEC | 1Q 2025 ending: 3/31/2025 | Rev: $154,883,000 +9.8% | Assets $903,393,000 | EPS -$0.28 | |
| 10x Genomics, Inc. (TXG) | 5/8/2025 4:07:15 PM | View | Financials | Earnings | SEC | 1Q 2025 | Rev $154,883,000 +9.8% | Assets $903,393,000 | EPS -$0.28 | Export Earnings Model | |
| 10x Genomics, Inc. (TXG) | 4/14/2025 4:25:34 PM | View | Proxy | SEC | Y 2024 | ||||||
| 10x Genomics, Inc. (TXG) | 2/13/2025 6:15:25 AM | Mid | View | Financials | 10-K | SEC | Y 2024 ending: 12/31/2024 | Rev: $610,785,000 -1.3% | Assets $918,636,000 | EPS -$1.52 | |
| 10x Genomics, Inc. (TXG) | 2/12/2025 4:11:53 PM | View | Financials | Earnings | SEC | Y 2024 | Rev $165,021,000 -10.3% | Assets $918,636,000 | EPS -$0.41 | Export Earnings Model | |
| 10x Genomics, Inc. (TXG) | 1/13/2025 8:51:24 AM | View | Financials | Earnings (Prelim) | SEC | Y 2024 | Export Earnings Model | ||||
| 10x Genomics, Inc. (TXG) | 10/29/2024 4:24:39 PM | Mid | View | Financials | 10-Q | SEC | 3Q 2024 ending: 9/30/2024 | Rev: $151,654,000 -1.3% | Assets $937,794,000 | EPS -$0.30 | |
| 10x Genomics, Inc. (TXG) | 10/29/2024 4:06:03 PM | View | Financials | Earnings | SEC | 3Q 2024 | Rev $151,654,000 -1.3% | Assets $937,794,000 | EPS -$0.30 | Export Earnings Model | |
| 10x Genomics, Inc. (TXG) | 10/9/2024 4:08:19 PM | View | Financials | Earnings (Prelim) | SEC | 3Q 2024 | Export Earnings Model | ||||
| 10x Genomics, Inc. (TXG) | 8/8/2024 4:27:15 PM | Mid | View | Financials | 10-Q | SEC | 2Q 2024 ending: 6/30/2024 | Rev: $153,104,000 +4.3% | Assets $929,668,000 | EPS -$0.32 | |
| 10x Genomics, Inc. (TXG) | 8/8/2024 4:19:06 PM | View | Financials | Earnings | SEC | 2Q 2024 | Rev $153,104,000 +4.3% | Assets $929,668,000 | EPS -$0.32 | Export Earnings Model | |
| 10x Genomics, Inc. (TXG) | 4/30/2024 4:28:02 PM | Mid | View | Financials | 10-Q | SEC | 1Q 2024 ending: 3/31/2024 | Rev: $141,006,000 +5.0% | Assets $922,913,000 | EPS -$0.50 | |
| 10x Genomics, Inc. (TXG) | 4/30/2024 4:07:28 PM | View | Financials | Earnings | SEC | 1Q 2024 | Rev $141,006,000 +5.0% | Assets $922,913,000 | EPS -$0.50 | Export Earnings Model | |
| 10x Genomics, Inc. (TXG) | 4/26/2024 4:29:03 PM | View | Proxy | SEC | Y 2023 | ||||||
| 10x Genomics, Inc. (TXG) | 2/15/2024 5:27:46 PM | Mid | View | Financials | 10-K | SEC | Y 2023 ending: 12/31/2023 | Rev: $618,727,000 +19.8% | Assets $965,143,000 | EPS -$2.18 | |
| 10x Genomics, Inc. (TXG) | 2/15/2024 4:08:22 PM | View | Financials | Earnings | SEC | Y 2023 | Rev $183,979,000 +17.8% | Assets $965,143,000 | EPS -$0.41 | Export Earnings Model | |
| 10x Genomics, Inc. (TXG) | 1/8/2024 9:01:38 AM | View | Financials | Earnings (Prelim) | SEC | Y 2023 | Export Earnings Model | ||||
| 10x Genomics, Inc. (TXG) | 11/3/2023 6:15:27 AM | Mid | View | Financials | 10-Q | SEC | 3Q 2023 ending: 9/30/2023 | Rev: $153,644,000 +17.2% | Assets $948,540,000 | EPS -$0.79 | |
| 10x Genomics, Inc. (TXG) | 11/2/2023 4:08:10 PM | View | Financials | Earnings | SEC | 3Q 2023 | Rev $153,644,000 +17.2% | Assets $948,540,000 | EPS -$0.79 | Export Earnings Model | |
| 10x Genomics, Inc. (TXG) | 8/4/2023 6:18:41 AM | Mid | View | Financials | 10-Q | SEC | 2Q 2023 ending: 6/30/2023 | Rev: $146,819,000 +28.1% | Assets $989,638,000 | EPS -$0.53 | |
| 10x Genomics, Inc. (TXG) | 8/3/2023 4:09:39 PM | View | Financials | Earnings | SEC | 2Q 2023 | Rev $146,819,000 +28.1% | Assets $989,638,000 | EPS -$0.53 | Export Earnings Model | |
| 10x Genomics, Inc. (TXG) | 5/4/2023 5:20:07 PM | Mid | View | Financials | 10-Q | SEC | 1Q 2023 ending: 3/31/2023 | Rev: $134,285,000 +17.3% | Assets $1,014,030,000 | EPS -$0.44 | |
| 10x Genomics, Inc. (TXG) | 5/3/2023 4:08:09 PM | View | Financials | Earnings | SEC | 1Q 2023 | Rev $134,285,000 +17.3% | Assets $1,014,030,000 | EPS -$0.44 | Export Earnings Model | |
| 10x Genomics, Inc. (TXG) | 4/28/2023 4:45:31 PM | View | Proxy | SEC | Y 2022 | ||||||
| 10x Genomics, Inc. (TXG) | 2/16/2023 4:56:47 PM | Mid | View | Financials | 10-K | SEC | Y 2022 ending: 12/31/2022 | Rev: $516,409,000 +5.3% | Assets $1,028,980,000 | EPS -$1.46 | |
| 10x Genomics, Inc. (TXG) | 2/15/2023 4:08:36 PM | View | Financials | Earnings | SEC | Y 2022 | Rev $156,232,000 +8.8% | Assets $1,028,980,000 | EPS -$0.15 | Export Earnings Model | |
| 10x Genomics, Inc. (TXG) | 11/3/2022 6:26:22 AM | Mid | View | Financials | 10-Q | SEC | 3Q 2022 ending: 9/30/2022 | Rev: $131,072,000 +4.6% | Assets $996,207,000 | EPS -$0.37 | |
| 10x Genomics, Inc. (TXG) | 11/2/2022 4:06:52 PM | View | Financials | Earnings | SEC | 3Q 2022 | Rev $131,072,000 +4.6% | Assets $996,207,000 | EPS -$0.37 | Export Earnings Model | |
| 10x Genomics, Inc. (TXG) | 8/9/2022 6:16:12 AM | Mid | View | Financials | 10-Q | SEC | 2Q 2022 ending: 6/30/2022 | Rev: $114,609,000 -1.1% | Assets $1,001,591,000 | EPS -$0.57 | |
| 10x Genomics, Inc. (TXG) | 8/8/2022 4:07:26 PM | View | Financials | Earnings | SEC | 2Q 2022 | Rev $114,609,000 -1.1% | Assets $1,001,591,000 | EPS -$0.57 | Export Earnings Model | |
| 10x Genomics, Inc. (TXG) | 7/14/2022 4:07:32 PM | View | Financials | Earnings (Prelim) | SEC | 2Q 2022 | Export Earnings Model | ||||
| 10x Genomics, Inc. (TXG) | 5/7/2022 4:01:35 AM | Mid | View | Financials | 10-Q | SEC | 1Q 2022 ending: 3/31/2022 | Rev: $114,496,000 +8.2% | Assets $1,003,251,000 | EPS -$0.38 | |
| 10x Genomics, Inc. (TXG) | 5/4/2022 4:08:46 PM | View | Financials | Earnings | SEC | 1Q 2022 | Rev $114,496,000 +8.2% | Assets $1,003,251,000 | EPS -$0.38 | Export Earnings Model | |
| 10x Genomics, Inc. (TXG) | 4/29/2022 4:17:25 PM | View | Proxy | SEC | Y 2021 | ||||||
| 10x Genomics, Inc. (TXG) | 2/18/2022 4:12:33 PM | Mid | View | Financials | 10-K | SEC | Y 2021 ending: 12/31/2021 | Rev: $490,490,000 +64.1% | Assets $1,018,826,000 | EPS -$0.53 | |
| 10x Genomics, Inc. (TXG) | 2/16/2022 4:09:35 PM | View | Financials | Earnings | SEC | Y 2021 | Rev $143,530,000 +27.9% | Assets $1,018,826,000 | EPS -$0.17 | Export Earnings Model | |
| 10x Genomics, Inc. (TXG) | 11/5/2021 4:11:16 PM | Mid | View | Financials | 10-Q | SEC | 3Q 2021 ending: 9/30/2021 | Rev: $125,297,000 +74.5% | Assets $990,572,000 | EPS -$0.15 | |
| 10x Genomics, Inc. (TXG) | 11/3/2021 4:07:12 PM | View | Financials | Earnings | SEC | 3Q 2021 | Rev $125,297,000 +74.5% | Assets $990,572,000 | EPS -$0.15 | Export Earnings Model | |
| 10x Genomics, Inc. (TXG) | 8/6/2021 4:14:51 PM | Mid | View | Financials | 10-Q | SEC | 2Q 2021 ending: 6/30/2021 | Rev: $115,842,000 +170.0% | Assets $977,579,000 | EPS -$0.10 | |
| 10x Genomics, Inc. (TXG) | 8/4/2021 4:05:25 PM | View | Financials | Earnings | SEC | 2Q 2021 | Rev $115,842,000 +170.0% | Assets $977,579,000 | EPS -$0.10 | Export Earnings Model | |
| 10x Genomics, Inc. (TXG) | 5/7/2021 4:11:49 PM | Mid | View | Financials | 10-Q | SEC | 1Q 2021 ending: 3/31/2021 | Rev: $105,821,000 +47.2% | Assets $954,033,000 | EPS -$0.11 | |
| 10x Genomics, Inc. (TXG) | 5/5/2021 4:23:27 PM | View | Financials | Earnings | SEC | 1Q 2021 | Rev $105,821,000 +47.2% | Assets $954,033,000 | EPS -$0.11 | Export Earnings Model | |
| 10x Genomics, Inc. (TXG) | 4/23/2021 4:14:36 PM | Mid | View | Financials | 10-K/A | SEC | Y 2020 ending: 12/31/2020 | Rev: $298,845,000 +21.5% | Assets $929,341,000 | EPS -$5.37 | |
| 10x Genomics, Inc. (TXG) | 4/23/2021 4:12:01 PM | View | Proxy | SEC | Y 2020 | ||||||
| 10x Genomics, Inc. (TXG) | 2/26/2021 4:34:21 PM | Mid | View | Financials | 10-K | SEC | Y 2020 ending: 12/31/2020 | Rev: $298,845,000 +21.5% | Assets $929,341,000 | EPS -$5.37 | |
| 10x Genomics, Inc. (TXG) | 2/17/2021 4:07:54 PM | View | Financials | Earnings | SEC | Y 2020 | Rev $112,218,000 +49.0% | Assets $929,341,000 | EPS -$4.09 | Export Earnings Model | |
| 10x Genomics, Inc. (TXG) | 11/12/2020 4:26:23 PM | Mid | View | Financials | 10-Q | SEC | 3Q 2020 ending: 9/30/2020 | Rev: $71,817,000 +17.3% | Assets $1,042,544,000 | EPS -$0.65 | |
| 10x Genomics, Inc. (TXG) | 11/10/2020 4:06:32 PM | View | Financials | Earnings | SEC | 3Q 2020 | Rev $71,817,000 +17.3% | Assets $1,042,544,000 | EPS -$0.65 | Export Earnings Model | |
| 10x Genomics, Inc. (TXG) | 8/12/2020 4:14:11 PM | Small | View | Financials | 10-Q | SEC | 2Q 2020 ending: 6/30/2020 | Rev: $42,905,000 -23.1% | Assets $582,802,000 | EPS -$0.41 | |
| 10x Genomics, Inc. (TXG) | 8/11/2020 4:16:33 PM | View | Financials | Earnings | SEC | 2Q 2020 | Rev $42,905,000 -23.1% | Assets $582,802,000 | EPS -$0.41 | Export Earnings Model | |
| 10x Genomics, Inc. (TXG) | 5/12/2020 4:16:21 PM | Small | View | Financials | 10-Q | SEC | 1Q 2020 ending: 3/31/2020 | Rev: $71,905,000 +34.2% | Assets $610,384,000 | EPS -$0.22 | |
| 10x Genomics, Inc. (TXG) | 5/11/2020 4:03:48 PM | View | Financials | Earnings | SEC | 1Q 2020 | Rev $71,905,000 +34.2% | Assets $610,384,000 | EPS -$0.22 | Export Earnings Model | |
| 10x Genomics, Inc. (TXG) | 4/24/2020 4:04:12 PM | View | Proxy | SEC | Y 2019 | ||||||
| 10x Genomics, Inc. (TXG) | 4/9/2020 4:02:39 PM | View | Financials | Earnings (Prelim) | SEC | 1Q 2020 | Export Earnings Model | ||||
| 10x Genomics, Inc. (TXG) | 2/27/2020 4:26:22 PM | Micro | View | Financials | 10-K | SEC | Y 2019 ending: 12/31/2019 | Rev: $245,893,000 +68.1% | Assets $45,604,000 | EPS -$0.80 | |
| 10x Genomics, Inc. (TXG) | 2/18/2020 4:03:12 PM | View | Financials | Earnings | SEC | Y 2019 | Rev $75,289,000 +48.9% | Assets $45,604,000 | EPS $0.41 | Export Earnings Model | |
| 10x Genomics, Inc. (TXG) | 11/12/2019 4:44:30 PM | Small | View | Financials | 10-Q | SEC | 3Q 2019 ending: 9/30/2019 | Rev: $61,207,000 +67.2% | Assets $572,815,000 | EPS -$0.33 | |
| 10x Genomics, Inc. (TXG) | 11/7/2019 4:10:56 PM | View | Financials | Earnings | SEC | 3Q 2019 | Rev $61,207,000 +67.2% | Assets $572,815,000 | EPS -$0.33 | Export Earnings Model |